The primary value of placebo controls in clinical trials is the minimization of bias.
Regular aspirin comes with risks and trials are still trying to figure out which patients are most likely to benefit. Tantalising data from more than a decade ago, external showed people who were ...
Today, TNO announces the establishment of ObjectivEye, a spin-off focused on the objective recruitment and selection of new employees through AI tools. ObjectivEye is launching a recruitment platform ...
LibreClinica is the community driven successor of OpenClinica. It is an open source clinical trial software for Electronic Data Capture (EDC) Clinical Data Management (CDM).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback